Occurrence of pharmaceutical and personal care products (PPCPs) in marine sediments in the Todos os Santos Bay and the north coast of Salvador, Bahia, Brazil

Journal of Soils and Sediments

Volumn 14, Issue 7, 2014, Pages 1278-1286

  Beretta, Magda ^a   Britto, Vicky ^a   Tavares, Tania Mascarenhas ^a   da Silva, Sonilda Maria Teixeira ^a   Pletsch, Adelmo Lowe ^b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b UNIVERSIDADE TECNOLÓGICA FEDERAL DO PARANÁ   (Brazil)

Author keywords

Emerging contaminants; Endocrine disrupting chemicals; Marine pollution; Sewage

Indexed keywords

CONCENTRATION (COMPOSITION); DRUG; ENDOCRINE DISRUPTOR; ENVIRONMENTAL INDICATOR; MARINE POLLUTION; MARINE SEDIMENT; ORGANIC POLLUTANT; SEDIMENT POLLUTION;

BAHIA; BRAZIL; SALVADOR; TODOS OS SANTOS BAY;

EID: 84901823459     PISSN: 14390108     EISSN: 16147480     Source Type: Journal    
DOI: 10.1007/s11368-014-0884-6     Document Type: Article

References (36)

1. Barceló D, Ayora C, Carrera J, Castaño S, Folch M, Calvo E, Alday J, Guasch H, Jofre J, Lema J, Alda M, Lucena F, Amich R, Muñoz I, Nieto J, Omil F, Ortiz I, Romaní A, Sabater S, Salgot M, Vila X, Sanz D, Suárez S, Torrens A (2008) Aguas continentales-Gestión de recursos hídricos, tratamiento y calidad del agua. Informes do Consejo Superior de Investigaciones Científicas, Madrid.
2. Borja P, Moraes L (2012) Programa de saneamento ambiental da Bahia, Bahia Azul: características, resultados e análise crítica. In: Barreto M (ed) Avaliação epidemiológica do impacto das ações do Programa Bahia Azul. Fiocruz, Salvador.
3. Conkle JL, Gan J, Anderson MA (2012) Degradation and sorption of commonly detected PPCPs in wetland sediments under aerobic and anaerobic conditions. J Soils Sediments 12: 1164-1173.
4. Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107(suppl 6): 907-938.
5. Di Guardo A, Calamari D, Benfenati E, Halling-Sorensen B, Zuccato E, Fanelli R (2004) Pharmaceuticals as environmental contaminants: modeling distribution and fate. In: Kümmerer K (ed) Pharmaceuticals in the environment: sources, fate, effects and risks, 2nd edn. Springer, Freiburg, pp 185-194.
6. Ellis J (2006) Pharmaceutical and personal care products in urban receiving waters. Environ Pollut 1: 184-189.
7. EEA - European Environmental Agency (2010) Pharmaceuticals in the environment: results of an EEA workshop held in Copenhagen, Jan 2009. Publication of the European Communities, Luxembourg.
8. EMBRAPA (1997) Manual de métodos de análise do solo. EMBRAPA, Rio de Janeiro.
9. EPA (1997) Special report on environmental endocrine disruption: an effects assessment and analysis. US Environmental Protection Agency (EPA) Report EPA/630/R-96/012, USEPA, Washington DC, USA.
10. EPA (2011) PPCP Research areas http://www. epa. gov/ppcp/work2. html. Accessed 15 Jan 2013.
11. Fent K, Weston A, Caminada D (2006) Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76: 122-159.
12. Fromme H, Uchler T, Otto T, Pilz K, Müller J, Wenzel A (2002) Occurrence of phthalates and bisphenol A and F in the environment. Water Res 36: 1429-1438.
13. Ghiselli G (2006) Avaliação das águas destinadas ao abastecimento público na região de Campinas: Ocorrência e determinação dos interferentes endócrinos (IE) e produtos farmacêuticos e de higiene pessoal (PFHP). Unpublished dissertation, Universidade de Campinas, Brazil.
14. Gros M, Pizzolato T, Petrovi M, Alda M, Barceló D (2008) Trace level determination of beta-blockers in waste waters by highly selective molecularly imprinted polymers extraction followed by liquid chromatography-quadrupole-linear ion trap mass spectrometry. J Chromatogr A 1189: 374-384.
15. Hartig C, Storm T, Jekel M (1999) Detection and identification of sulphonamide drugs in municipal waste water by liquid chromatography coupled with electrospray ionisation tandem mass spectrometry. J Chromatogr A 854: 163-173.
16. Heberer T (2002) Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 131: 5-17.
17. Hirsch R, Ternes T, Haberer K, Kratz K (1999) Occurrence of antibiotics in the aquatic environment. Sci Total Environ 225: 109-118.
18. Huggett D, Brooks B, Peterson B, Foran C, Schlenk D (2002) Toxicity of select beta adrenergic receptor-blocking pharmaceuticals on aquatic organisms. Arch Environ Contam Toxicol 43: 229-235.
19. Kulshrestha P, Giese R, Aga D (2004) Investigating the molecular interactions of oxytetracycline in clay and organic matter: insights on factors affecting its mobility in soil. Environ Sci Technol 38: 4097-4105.
20. Kümmerer K (2004) Pharmaceuticals in the environment: sources, fate, effects and risks. Springer, Freiburg.
21. Mulroy A (2001) When the cure is the problem. Water Environ Technol 13: 32-36.
22. Nash J, Kime D, van Der Ven L, Wester P, Brion F, Maack G, Stahlschmidt-Allner P, Tyler C (2004) Long-term exposure to environmental concentrations of the pharmaceutical ethynylestradiol causes reproductive failure in fish. Environ Health Perspect 112(17): 1725-1733.
23. Pan B, Xing B (2011) Pharmaceuticals and personal care products in soils and sediments. In: Xing B, Senesi N, Huang P (eds) Biophysico-chemical processes of anthropogenic organic compounds in environmental systems. Wiley, Massachusetts, pp 185-213.
24. Pan B, Ning P, Xing B (2009) Humic substances. Review series. Part V-sorption of pharmaceuticals and personal care products. Environ Sci Pollut Res 16: 106-116.
25. Pawlowski S, van Aerle R, Tyler C, Braunbeck T (2004) Effects of 17a-ethinylestradiol in a fathead minnow (Pimephales promelas) gonadal recrudescence assay. Ecotoxicol Environ Saf 57: 330-345.
26. Peters R, Courtenay S, Cagampan S, Hewitt M, Maclatchy D (2007) Effects on reproductive potential and endocrine status in the mummichog (Fundulus heteroclitus) after exposure to 17alpha-ethynylestradiol in a short-term reproductive bioassay. Aquat Toxicol 85: 154-166.
27. Pletsch A, Beretta M, Tavares T (2010) Distribuição espacial de compostos orgânicos de estanho em sedimentos costeiros e em Phallusia nigra da Baía de Todos os Santos e litoral norte da Bahia-Brasil. Quim Nova 33(2): 451-457.
28. Salomons W, Stigliani WM (1995) Biogeodynamics of pollutants in soils and sediments. Springer, Berlin.
29. Sanderson H, Brain R, Johnson D, Wilson C, Solomon K (2004) Toxicity classification and evaluation of four pharmaceuticals classes: antibiotics, antieoplastics, cardiovascular, and sex hormones. Toxicology 203(1): 27-40.
30. SESAB - Secretaria da Saúde do Estado da Bahia (2009) Assistência farmacêutica na atenção básica. Planilha de consumos médios mensais de medicamentos de março de 2009 à agosto de 2009. SESAB, Salvador, Brazil.
31. Souza E (1978) Administração de medicamentos e preparo de soluções. Cultura Médica, Rio de Janeiro.
32. Stumpf M, Ternes T, Wilken R, Rodrigues S, Baumann W (1999) Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 225: 135-141.
33. Ternes T (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 11: 3245-3260.
34. Ternes T, Andersen H, Gilberg D, Bonerz M (2002a) Determination of estrogens in sludge and sediments by liquid extraction and GC/MS/MS. Anal Chem 74: 3498-3504.
35. Ternes T, Meisenheimer M, Mcdowell D, Sacher F, Brauch H, Gulde B, Preuss G, Wilme U, Seibert N (2002b) Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 36: 3855-3863.
36. WHO/UNEP/ILO (2004) Report of the joint IPCS-Japan workshop on endocrine disruptors: research needs and future directions. Tokyo, Japan. Available on http://ec. europa. eu/research/endocrine/pdf/japan_workshop_en. pdf. Accessed 22 Jan 2013.